Xinghua Dingli
VC Fund
Xinghua Dingli is an investment company.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 43%
Last updated:
For AI agents: llms.txt
Industries Xinghua Dingli invests in
Stages Xinghua Dingli invests in
Countries Xinghua Dingli invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.4M–$14M
Investment Focus
Industry
- Biotechnology 7 (50%)
- Medical 3 (21%)
- Biopharma 3 (21%)
- Health Care 3 (21%)
- Pharmaceutical 3 (21%)
Stage
- Seed 5 (36%)
- Series A 3 (21%)
- Series B 2 (14%)
- Venture - Series Unknown 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
He Jiongling
Investment Director
|
Investment Director | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Gaowei Medicine
|
Gaowei Medicine is a drug discovery platform for developing new drugs for key intractable diseases such as cancer and neurological diseases. | Seed / Oct 14, 2026 | |
| Kaiwang Data is a one-stop shop for data solutions. It focuses on offering complete data labeling solutions for automakers and businesses involved in autonomous driving. | $14.8M / Venture - Series Unknown / Aug 04, 2026 | ||
Puyuan Bio
|
Primobiology is a developer of live microbial drugs for immune diseases. | Seed / May 30, 2024 | |
Puyuan Bio
|
Puyuan Bio engages in the clinical quantitative detection of tumor-specific mRNA in human peripheral blood. Its technology can provide an important clinical diagnosis basis for the presence of hematogenous spread of tumor cells and dynamic monitoring of the disease.The company has a talented team with doctoral tutors, doctors, and masters as themain body, and has 9 national invention patents in related fields. The company was approved by the Ministry of Science and Technology of Science and Technology Small and Medium Enterprises Technology Innovation Fund and passed the acceptance inspection. It is an enterprise settled in the technology transfer plan of Anhui Province and has been included in the Hefei Shuangqian Project. It was supported by the Development and Reform Commission in 2018.The registration application materials of the cytokeratin 19 (CK19) mRNA nucleic acid detection kit (PCR-fluorescent probe method) have been accepted by the State Food and Drug Administration, the on-site inspection of the medical device production quality management standard has been passed, and the approval number will be obtained soon. When it is put into production, it will contribute to public health. | $1.4M / Seed / May 30, 2024 | |
Inkedi Microelectronics
|
Inkodi Electronics is a manufacturer of electronic components that specializes in integrated circuit design, chip R&D and design, analog circuit layout design, and electronic component retail. | $14.1M / Seed / Dec 28, 2023 | |
| Hydrogen Aviation Technology is committed to innovative applications of lightweight hydrogen fuel stacks. Its self-developed hydrogen-powered UAV has reached the international leading level. | Series A / Nov 07, 2023 | ||
| Tianji Jishi is a biopharmaceutical company that specializes in researching mitochondria. | Series A / Oct 08, 2023 | ||
| Blue Aspirations was formed to use statistics to accelerate the global adoption of renewable energy. Blue Aspirations aims to face the challenges of the next century by leveraging software development and technical knowledge in the renewables business. | Series B / Sep 22, 2023 | ||
| Hangzhou Weiyuan Biotechnology is a synthetic biology research and development company that specializes in enzyme advancement. | Seed / Jun 30, 2023 | ||
| Nuoyu Pharmaceutical is a medical innovative drug producer that emphasizes in nuclear drug research and drug screening. | Series A / May 13, 2023 | ||
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Xinghua Dingli invest in?
Xinghua Dingli invests primarily in Biotechnology, Medical and Biopharma startups, most often at Seed and Series A stage. Most of the 14 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Xinghua Dingli invest in?
Xinghua Dingli typically joins rounds of $1.4M–$14M at Seed. These are whole funding-round sizes, not Xinghua Dingli's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Xinghua Dingli took part in.
How do I contact Xinghua Dingli?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Xinghua Dingli?
The team at Xinghua Dingli includes He Jiongling (Investment Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
